ADHF clinical trials at UCSF

1 research study open to eligible people

Acute decompensated heart failure is when the heart cannot keep fluid balanced and symptoms get worse quickly. UCSF is studying medical care versus a small blood pump device for patients who are hospitalized. Trials look at short hospital outcomes and heart function after treatment.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Our lead scientists for ADHF research studies include .

Last updated: